Most Recent
Puma has failed in its bid for leave to appeal a decision that found its ‘Procat’ trade mark was deceptively similar to US machinery manufacturer Caterpillar’s CAT marks.
Bangkok Broadcasting and Seven Networks have settled two lawsuits over the Thai broadcaster's registration of '7' marks in Australia.
The High Court has granted special leave to a cosmetic company to challenge a judgment finding it infringed Botox maker Allergan's trade marks by marketing its topical creams as Botox alternatives.
Seven Network is in negotiations with Bangkok Broadcasting to resolve their spat over the Thai broadcaster's proposed 7HD trade mark, which was found to be deceptively similar to Seven's mark.
Bristol-Myers Squibb unit Celgene has dropped a lawsuit accusing Indian generics company Dr Reddy's Laboraties of threatening to infringe its patent for Revlimid with the planned launch of a generic version of the blockbuster cancer drug in Australia.
Indian generics giant Dr Reddy’s Laboratories must give Bristol-Myers Squib unit Celgene Corporation three months’ notice before deciding to sell generic versions of blockbuster cancer drug Revlimid in Australia.
Botox drug maker Allergan has secured an injunction against a Sydney-based cosmetics company which sought to “leverage” the reputation of the well-known injectable to sell its Freezeframe line of anti-aging topical creams.
Sportswear brand Puma has launched an appeal against a Federal Court decision that found it’s ‘Procat’ trade mark was deceptively similar to US machinery manufacturer Caterpillar’s CAT marks.
Botox maker Allergan has successfully challenged a Federal Court judgment dismissing its trade mark lawsuit against an Australian company selling topical creams as an alternative to Botox injections.
US machinery manufacturer Caterpillar has won its appeal of a decision approving sportswear brand Puma’s 'Procat' trade mark application, with a judge finding “a significant number” of consumers might be confused by the mark.